Healthcare Nanotechnology Market Analysis, By Application (Drug Delivery System, Molecular Diagnostics, Clinical Oncology, Clinical Neurology, Clinical Cardiology, Anti-Inflammatory, Anti-Infective), Market Size, Regional Outlook, Competitive Strategies And Forecasts, 2015 To 2022

Industry Insights

The application of nanotechnology into healthcare sector is referred as nanotechnology healthcare. Continuous innovation in nanotechnology for improvement of nanomedicines is the main driver for nanotechnology market over the forecast period. Nanotechnology helps to cure biological system of sub-microscopic and molecular parts by repairing, constructing, monitoring and controlling them.

Increasing demand of nanotechnology owing to the development programs funded by both government and private sectors organization for cardiovascular and neurology based diseases is also expected to drive the market for healthcare nanotechnology. Increasing drug efficiency coupled with huge monetary investment are anticipated for the further growth of this market. Increasing application of nanotechnology for the purpose of disease diagnosis, prevention and therapy is  also expected to further fuel the growth rate of this market.

Browse Detail Report with TOC @ http://www.hexaresearch.com/research-report/healthcare-nanotechnology-industry/

Application Insights

On the basis of application, the global healthcare nanotechnology market is divided into neurology, oncology, cardiovascular, anti-infective, anti-inflammatory and other applications of nanomedicines. Other application is further divided into dental, orthopedic, hematology, kidney andophthalmology. In 2013, the global nanotechnology for oncology dominated the entire market for healthcare nanotechnology owing to increasing efficiency of its nano-particles to fight against tumor and cancers causing tissues.

End Use Insights

On the basis of end use, market is segmented into hospitals, clinics and ambulatories. Hospital is anticipated to show the highest growth rate over next decade owing to increasing number of chronic diseases and increasing awareness about prevention these diseases. Large to medium hospitals has adopted nanotechnology more than small hospitals due to large hospitals have high budget comparison with small ones.

Request a Sample copy of This Report @ http://www.hexaresearch.com/sample/248

Regional Insights

Geographically, the global healthcare nanotechnology market is divided into North America, Europe, Asia Pacific and Row. In the year 2014, North America consists the largest share in this market. Presence of sophisticated technology and huge investment in becoming technologically competitive are anticipated reasons for its further lead in the next six years. Asia Pacific region is expected to witness highest growth rate over the forecast period owing to increasing population base, increasing personal disposable income and growth in outsourcing & offshoring of medical sectors. The emerging countries possess huge market potential market due to high demand for latest technology and large idle market.

Competitors Insights

Some of the key players of the global healthcare nanotechnology market are Abbott Laboratories, UCB S.A., Sigma-Tau Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Merck & Company Inc., NanosphereInc., GE Healthcare, Celgene Corporation, Mallinckrodt plc., and CombiMatrix Corporation. Since the market is very competitive, firms are going through many mergers, acquisitions, geographical expansion and NPD for retaining their present customers.

Table of Contents

Chapter 1. Executive Summary
1.1. Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs)

Chapter 2. Nanotechnology Healthcare Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Nanotechnology Healthcare Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Nanotechnology Healthcare market PESTEL Analysis, 2013

Chapter 3. Nanotechnology Healthcare Application Outlook
3.1. Drug Delivery System

3.2. Molecular Diagnostics
3.3. Clinical Oncology
3.4. Clinical Neurology
3.5. Clinical Cardiology
3.6. Anti-Inflammatory and Anti-Infective applications

Browse Biotechnology Market Research Related Reports @ http://www.hexaresearch.com/research-category/biotechnology-industry/

Chapter 4. Nanotechnology Healthcare Regional Outlook
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. RoW

Chapter 5 Competitive Landscape
5.1 Abbott Laboratories.
5.2 CombiMatrix Corporation
5.3 Celgene Corporation
5.4 Mallinckrodt plc.
5.5 GE Healthcare
5.6 Johnson & Johnson
5.7 Merck & Company Inc.
5.8 Nanosphere Inc.
5.9 Pfizer Inc.
5.10 Sigma-Tau Pharmaseuticals Inc.
5.11 Teva Pharmaseuticals Industries Ltd.
5.12 UCB SA

Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources

Browse Full Report @ http://www.hexaresearch.com/research-report/healthcare-nanotechnology-industry/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit our Blogs: http://hexaresearch2015.blogspot.in/